IGC Pharma (IGC) Minority Interest (2011 - 2017)
IGC Pharma (IGC) posted quarterly Minority Interest of -$9007.0 for Q4 2017, little changed year-over-year from -$9014.0 in Q4 2016, and down 1.73% quarter-over-quarter from -$8854.0 in Q3 2017.
IGC Pharma (IGC) Minority Interest (2011 - 2017) Analysis & Trends
IGC Pharma (IGC) has reported Minority Interest for 7 consecutive years, with -$9007.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Minority Interest changed 0.08% year-over-year to -$9007.0; the TTM figure through Dec 2017 stood at -$9007.0 (changed 0.08% YoY), while the FY2017 annual figure was -$8836.0, down 101.87% from the prior year.
- Minority Interest eased to -$9007.0 in Q4 2017 per IGC's latest filing, from -$8854.0 in the prior quarter.
- Across five years, Minority Interest topped out at $576803.0 in Q2 2014 and bottomed at -$9007.0 in Q4 2017.
- Historically, Minority Interest has averaged $393083.6 across 5 years, with a median of $523033.0 in 2014.
- Annual changes were most pronounced in 2014 — Minority Interest advanced 6.96% — and 2017, when it plunged 102.1%.
- IGC Pharma's Minority Interest stood at $531772.0 in 2013, then increased by 4.67% to $556612.0 in 2014, then grew by 2.35% to $569702.0 in 2015, then tumbled by 101.58% to -$9000.0 in 2016, then dropped by 0.08% to -$9007.0 in 2017.
- Business Quant data shows IGC's Minority Interest at -$9007.0 in Q4 2017, -$8854.0 in Q3 2017, and -$8790.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -9,007.00 |
| Sep 30, 2017 | -8,854.00 |
| Jun 30, 2017 | -8,790.00 |
| Mar 31, 2017 | -8,836.00 |
| Dec 31, 2016 | -9,000.00 |
| Sep 30, 2016 | 420,633.00 |
| Jun 30, 2016 | 490,794.00 |
| Mar 31, 2016 | 472,057.00 |
| Dec 31, 2015 | 569,702.00 |
| Sep 30, 2015 | 527,954.00 |
| Jun 30, 2015 | 544,605.00 |
| Mar 31, 2015 | 515,927.00 |
| Dec 31, 2014 | 556,612.00 |
| Sep 30, 2014 | 564,722.00 |
| Jun 30, 2014 | 576,803.00 |
| Mar 31, 2014 | 518,112.00 |
| Dec 31, 2013 | 531,772.00 |
| Sep 30, 2013 | 539,092.00 |
| Jun 30, 2013 | 539,273.00 |
| Mar 31, 2013 | 538,100.00 |